Considerations for Cell Therapy Media Development

11 Aug 2021
Considerations-education-content

Cell and gene therapy development is advancing rapidly and creates unique challenges due to the complexity of developing processes for delivery of a living therapeutic. View our infographic to learn why custom-formulated cell culture media is the best solution to ensure successful cell therapy development.

Download Guide

Share this article

Brad N. Taylor, Ph.D.
Dr. Brad Taylor has 17 years of experience commercializing products for scientists in both academia and industry before joining Nucleus Biologics. Most recently, Dr. Taylor was the Director of Global Marketing at HemaCare, supporting the needs of the cellular therapy industry. Prior to HemaCare, Dr. Taylor spent 11 years at PerkinElmer supporting in vivo imaging platforms and has held leadership roles in technical support, product management, and marketing. Dr. Taylor holds a M.S. in Microbiology and Immunology from Louisiana State University Health Sciences Center and a Ph.D. in Molecular Biology and Genetics from Friedrich-Alexander University in Germany.